UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 36

Sortiert nach

p53 nuclear accumulation as an early indicator of lethal prostate cancer

British journal of cancer, 2019-10, Vol.121 (7), p.578-583

2019

Volltextzugriff (PDF)

Aberrant Neuropeptide Y and Macrophage Inhibitory Cytokine-1 Expression Are Early Events in Prostate Cancer Development and Are Associated with Poor Prognosis

Cancer epidemiology, biomarkers & prevention, 2006-04, Vol.15 (4), p.711-716

2006

Volltextzugriff (PDF)

Preclinical validation of anti-TMEFF2-auristatin E–conjugated antibodies in the treatment of prostate cancer

Molecular cancer therapeutics, 2004-08, Vol.3 (8), p.921-932

2004

Volltextzugriff (PDF)

A Preoperative Nomogram Identifying Decreased Risk of Positive Pelvic Lymph Nodes in Patients With Prostate Cancer

The Journal of urology, 2003-11, Vol.170 (5), p.1798-1803

2003

Volltextzugriff (PDF)

Frequent loss of estrogen receptor-β expression in prostate cancer

Cancer research (Chicago, Ill.), 2001-07, Vol.61 (14), p.5331-5335

2001

Volltextzugriff (PDF)

Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse

Cancer research (Chicago, Ill.), 2003-07, Vol.63 (14), p.4196-4203

2003

Volltextzugriff (PDF)

Altered expression of androgen receptor in the malignant epithelium and adjacent stroma is associated with early relapse in prostate cancer

Cancer research (Chicago, Ill.), 2001-01, Vol.61 (2), p.423-427

2001

Volltextzugriff (PDF)

Prognostic significance of Gleason pattern in patients with Gleason score 7 prostate carcinoma

Cancer, 2003-12, Vol.98 (12), p.2560-2565

2003

Volltextzugriff (PDF)

Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer

The Prostate, 2007-07, Vol.67 (10), p.1081-1090

2007

Volltextzugriff (PDF)

Lower levels of nuclear β‐catenin predict for a poorer prognosis in localized prostate cancer

International journal of cancer, 2005-01, Vol.113 (3), p.415-422

2005

Volltextzugriff (PDF)

Prognostic Significance of Pathologic Features in Localized Prostate Cancer Treated With Radical Prostatectomy: Implications for Staging Systems and Predictive Models

Journal of clinical oncology, 2001-08, Vol.19 (16), p.3692-3705

2001

Volltextzugriff (PDF)

Prognostic significance of p53 nuclear accumulation in localized prostate cancer treated with radical prostatectomy

Cancer research (Chicago, Ill.), 2000-03, Vol.60 (6), p.1585-1594

2000

Volltextzugriff (PDF)

Validation Study of the Accuracy of a Postoperative Nomogram for Recurrence After Radical Prostatectomy for Localized Prostate Cancer

Journal of clinical oncology, 2002-02, Vol.20 (4), p.951-956

2002

Volltextzugriff (PDF)

Elevated levels of peritumoral chondroitin sulfate are predictive of poor prognosis in patients treated by radical prostatectomy for early-stage prostate cancer

Cancer research (Chicago, Ill.), 1999-05, Vol.59 (10), p.2324-2328

1999

Volltextzugriff (PDF)

Is Year of Radical Prostatectomy a Predictor of Outcome in Prostate Cancer?

The Journal of urology, 2004-02, Vol.171 (2), p.692-696

2004

Volltextzugriff (PDF)

Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: Importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion

Cancer, 2003-04, Vol.97 (8), p.1884-1893

2003

Volltextzugriff (PDF)

Overexpression of the Cell Cycle Inhibitor p16INK4A in High-grade Prostatic Intraepithelial Neoplasia Predicts Early Relapse in Prostate Cancer Patients

Clinical cancer research, 2001-03, Vol.7 (3), p.544-550

2001

Volltextzugriff (PDF)

Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy

Cancer, 2003-04, Vol.97 (8), p.1884-1893

2003

Volltextzugriff (PDF)

Effect of age on patterns of theophylline metabolism

Clinical pharmacology and therapeutics, 1980-10, Vol.28 (4), p.456-462

1980

Volltextzugriff (PDF)

Zinc-alpha2-glycoprotein expression as a predictor of metastaticprostatecancer following radical prostatectomy

JNCI : Journal of the National Cancer Institute, 2006, Vol.98 (19), p.1420-1424

2006

Volltextzugriff (PDF)

Lower levels of nuclear [beta]-catenin predict for a poorer prognosis in localized prostate cancer

International journal of cancer, 2005-01, Vol.113 (3), p.415-422

2005

Volltextzugriff (PDF)

Multiple atypical nevi: a cutaneous marker of germ cell tumors

Journal of clinical oncology, 1994-11, Vol.12 (11), p.2284-2287

1994

Volltextzugriff (PDF)

Cigarette smoking and theophylline clearance and metabolism

Clinical pharmacology and therapeutics, 1981-10, Vol.30 (4), p.491-496

1981

Volltextzugriff (PDF)

A phase I and pharmacokinetic study of diamminecyclobutane-dicarboxylatoplatinum (NSC 24 1240)

Cancer research (Chicago, Ill.), 1983-09, Vol.43 (9), p.4470-4473

1983

Volltextzugriff (PDF)

Pharmacokinetics of tiazofurin in the plasma and cerebrospinal fluid of rhesus monkeys

Cancer research (Chicago, Ill.), 1985-05, Vol.45 (5), p.2037-2039

1985

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(35)
Reviews
(1)

Sprache

Englisch
(36)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

p53 nuclear accumulation as an early indicator of lethal prostate cancer

Aberrant Neuropeptide Y and Macrophage Inhibitory Cytokine-1 Expression Are Early Events in Prostate Cancer Development and Are Associated with Poor Prognosis

Preclinical validation of anti-TMEFF2-auristatin E–conjugated antibodies in the treatment of prostate cancer

A Preoperative Nomogram Identifying Decreased Risk of Positive Pelvic Lymph Nodes in Patients With Prostate Cancer

Frequent loss of estrogen receptor-β expression in prostate cancer

Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse

Altered expression of androgen receptor in the malignant epithelium and adjacent stroma is associated with early relapse in prostate cancer

Prognostic significance of Gleason pattern in patients with Gleason score 7 prostate carcinoma

Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer

Lower levels of nuclear β‐catenin predict for a poorer prognosis in localized prostate cancer

Prognostic Significance of Pathologic Features in Localized Prostate Cancer Treated With Radical Prostatectomy: Implications for Staging Systems and Predictive Models

Prognostic significance of p53 nuclear accumulation in localized prostate cancer treated with radical prostatectomy

Validation Study of the Accuracy of a Postoperative Nomogram for Recurrence After Radical Prostatectomy for Localized Prostate Cancer

Elevated levels of peritumoral chondroitin sulfate are predictive of poor prognosis in patients treated by radical prostatectomy for early-stage prostate cancer

Is Year of Radical Prostatectomy a Predictor of Outcome in Prostate Cancer?

Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: Importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion

Overexpression of the Cell Cycle Inhibitor p16INK4A in High-grade Prostatic Intraepithelial Neoplasia Predicts Early Relapse in Prostate Cancer Patients

Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy

Effect of age on patterns of theophylline metabolism

Zinc-alpha2-glycoprotein expression as a predictor of metastaticprostatecancer following radical prostatectomy

Lower levels of nuclear [beta]-catenin predict for a poorer prognosis in localized prostate cancer

Multiple atypical nevi: a cutaneous marker of germ cell tumors

Cigarette smoking and theophylline clearance and metabolism

A phase I and pharmacokinetic study of diamminecyclobutane-dicarboxylatoplatinum (NSC 24 1240)

Pharmacokinetics of tiazofurin in the plasma and cerebrospinal fluid of rhesus monkeys

Aktive Filter

Suchergebnisse filtern